Episode three of "The Power of Persistence" focuses on pipeline development in the biotech industry. Phil Serlin, CEO of BioLineRX, discusses how companies balance launching one product while maintaining pipeline development. Phil emphasizes the versatility of their platform molecule and the various applications it offers, such as stem cell mobilization for different transplantation types and gene therapy. Phil shares insights into how BioLineRX identifies potential partners and leverages existing expertise to expand their pipeline strategically. The discussion underscores the dynamic nature of the biotech industry and the need for companies to seize the moment while preparing for the future.